PDRX - PD-Rx Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/20166/30/20156/30/20146/30/2013
Total Revenue21,467.73819,386.8929,120.56426,019.486
Cost of Revenue13,899.84611,712.71218,938.97317,806.81
Gross Profit7,567.8927,674.17810,181.5918,212.676
Operating Expenses
Research Development----
Selling General and Administrative6,805.6296,793.4737,090.7496,273.304
Non Recurring----
Others----
Total Operating Expenses20,705.47518,506.18526,029.72224,080.114
Operating Income or Loss762.263880.7053,090.8421,939.372
Income from Continuing Operations
Total Other Income/Expenses Net36.03443.80333.04725.81
Earnings Before Interest and Taxes762.263880.7053,090.8421,939.372
Interest Expense--0.049-0.397-5.87
Income Before Tax798.297924.5083,123.8891,965.182
Income Tax Expense290.625383.961,159.747734.371
Minority Interest----
Net Income From Continuing Ops507.672540.5481,964.1421,230.811
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income507.672540.5481,964.1421,230.811
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares507.672540.5481,964.1421,230.811